Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
SENSORCAINE ASPEN PHARMACARE CANADA INC. Anticipated shortage 2.5MG Updated Report 2024-04-30 225255
DIPRIVAN 1% ASPEN PHARMACARE CANADA INC. Anticipated shortage 10MG Updated Report 2024-04-30 222698
DIPRIVAN 1% ASPEN PHARMACARE CANADA INC. Anticipated shortage 10MG Updated Report 2024-04-30 222695
SENSORCAINE ASPEN PHARMACARE CANADA INC. Anticipated shortage 5MG Updated Report 2024-04-30 222686
XYLOCAINE 1% W EPINEPHRINE 1:200000 ASPEN PHARMACARE CANADA INC. Anticipated shortage 5MCG 10MG Updated Report 2024-04-30 222673
XYLOCAINE 2% W EPINEPHRINE 1:200000 ASPEN PHARMACARE CANADA INC. Anticipated shortage 5MCG 20MG Updated Report 2024-04-30 222670
XYLOCAINE 2% WITH EPINEPHRINE 1:200000 ASPEN PHARMACARE CANADA INC. Anticipated shortage 0.005MG 20MG Updated Report 2024-04-30 220855
EMLA CREAM ASPEN PHARMACARE CANADA INC. Anticipated shortage 2.5% 2.5% Updated Report 2024-04-30 222665
XYLOCAINE 1% W EPINEPHRINE 1:100000 ASPEN PHARMACARE CANADA INC. Anticipated shortage 0.01MG 10MG Updated Report 2024-04-30 220858
DESFERAL 500MG NOVARTIS PHARMACEUTICALS CANADA INC Actual shortage 500MG Updated Report 2024-04-30 222962

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
PANECTYL SEARCHLIGHT PHARMA INC To be discontinued 2.5MG New Report 2024-04-30 226633
ISENTRESS MERCK CANADA INC To be discontinued 25MG Updated Report 2024-04-29 204164
ISENTRESS MERCK CANADA INC To be discontinued 100MG Updated Report 2024-04-29 204160
PANECTYL SEARCHLIGHT PHARMA INC To be discontinued 5MG New Report 2024-04-26 226355
DELATESTRYL BAUSCH HEALTH, CANADA INC. Discontinued 200MG Updated Report 2024-04-26 221772